Is a complete BNTX research report available?

No complete published report is available for BioNTech SE (BNTX) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

BioNTech SE (BNTX)

NASDAQ: BNTX · USD

$93.0

+0.50 (+0.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-30 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first BNTX analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	23.5B
Revenue (ttm)	3.2B
Net income (ttm)	-1.4B
EPS (ttm)	-$5.89
Shares out	252.9M
Volume	739,945
Beta	1.32
Price target	$123	+31.9%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 3.2B
Net income (ttm): -1.4B
EPS (ttm): -$5.89
Market cap: 23.5B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All BNTX indicators

Market & fundamental data

Available fields

227

Groups with data

Currency

EUR

Showing 227 of 227 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001776985
Company name	BioNTech SE
Country	Germany
Country code	US
Cusip	09075V102
Employees	7,807
Employees Change	1,035%
Employees Change Percent	15.28
Enterprise value	$8.1B
Exchange	NASDAQ
Financial currency	EUR
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2019-10-10
Isin	US09075V1026
Last refreshed	2026-07-30
Market cap	$23.5B
Market cap category	Large-Cap
Price	$92.95
Price currency	USD
Rev Per Employee	414,295.58x
Sector	Healthcare
Sector PE	45.6
Sector PE Fwd	24.3
Sic	2836
Symbol	BNTX
Website	https://www.biontech.de

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.14%
EV Sales Forward	3.7x
EV/FCF	11.09x
EV/Sales	2.49x
FCF yield	3.09%
P/B ratio	1.09x
P/S ratio	7.27x
PS Forward	10.81x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-57.62%
EBITDA Margin	-40.45%
FCF margin	22.55%
Gross margin	78.65%
Gross Profit	$2.5B
Gross Profit Growth	1.19%
Gross Profit Growth Q	-52.83%
Gross Profit Growth3 Y	-40.39%
Gross Profit Growth5 Y	-0.09%
Net Income	$-1.4B
Net Income Growth Years	0%
Pretax Margin	-41.83%
Profit Margin	-44.64%
Profit Per Employee	$-184,935
ROA	-4.18
Roa5y	27.18
ROCE	-7.98
ROE	-6.66
Roe5y	41.92
ROIC	-25.58
Roic5y	51.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-17.6%
Cagr3y	-4.71%
Cagr5y	-21.43%
EPS Growth Years	0
FCF Growth3 Y	-57.97%
OCF Growth3 Y	-54.83%
Revenue Growth	2.15x
Revenue Growth Q	-35.39x
Revenue Growth Years	1x
Revenue Growth3 Y	-38.76x
Revenue Growth5 Y	2.31x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.13
Assets	$24.3B
Cash	$15.8B
Current Assets	$17.8B
Current Liabilities	$2B
Debt	$349.1M
Debt Equity	$0.02
Debt FCF	$0.48
Equity	$21.6B
Interest Coverage	-106.2
Liabilities	$2.7B
Long Term Assets	$6.5B
Long Term Liabilities	$715.2M
Net Cash	$15.5B
Net Cash By Market Cap	$65.75
Net Cash Growth	-0.22%
Net Debt Equity	$-0.72
Net Debt FCF	$-21.29
Tangible Book Value	$19.3B
Tangible Book Value Per Share	$76.51
WACC	11.42

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	8.8
Inventory Turnover	3.34
Net Working Capital	$134.8M
Quick ratio	8.11
Working Capital	$15.9B
Working Capital Turnover	$0.23

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-1.91%
Dividend per share	$0
Dividend Yield	0%
Last Dividend	$1.55

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-17.59%
200-day SMA	98.32
3Y total return	-13.47%
50-day SMA	91.21
50-day SMA vs 200-day SMA	50under200
5Y total return	-70.06%
All Time High	464
All Time High Change	-79.97%
All Time High Date	2021-08-10
All Time Low	12.53
All Time Low Change	642.12%
All Time Low Date	2019-10-14
ATR	2.43
Beta	1.32
Beta1y	1.56
Beta2y	1.23
Ch YTD	-2.36
High	94.38
High52	124
High52 Date	2026-01-22
High52ch	-25.04%
Low	91.93
Low52	79.52
Low52 Date	2026-03-10
Low52ch	16.89%
Ma50ch	1.91%
Premarket Change Percent	-0.92
Premarket Price	$91.6
Premarket Volume	910
Price vs 200-day SMA	-5.46%
RSI	53.62
RSI Monthly	45.44
RSI Weekly	47.15
Sharpe ratio	-0.35x
Sortino ratio	-0.34
Total Return	-1.91%
Tr YTD	-2.36
Tr1m	1.9%
Tr1w	1.22%
Tr3m	-8.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	20
Analyst Count Top	12
Analyst Price Target Top	$131
Analyst Ratings	Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-2.34
Earnings Revenue Estimate	182,020,000x
Earnings Revenue Estimate Growth	-38.44x
Operating Income	$-1.6B
Operating margin	-50.35
Price target	$123
Price Target Change	$31.89
Price Target Change Top	$40.67

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	110,098,535%
Float Percent	43.54%
Net Borrowing	-12,274,147.1
Shares Insiders	16.25%
Shares Institutions	20.25%
Shares Out	252,884,261
Shares Qo Q	3.81%
Shares Yo Y	1.91%
Short Ratio	2.73
Short Shares	3.32

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$630.5M
Adjusted OCF	840,377,584.9
Average Volume	758,878.35x
Bv Per Share	85.25
CAPEX	$-209.9M
Ch1m	1.9
Ch1w	1.22
Ch1y	-17.59
Ch3m	-8.93
Ch3y	-13.47
Ch5y	-70.35
Ch6m	-19.98
Change	0.54%
Change From Open	0.7
Close	92.45
Days Gap	-0.16
Depreciation Amortization	253,627,469.3
Dollar Volume	68,777,887.8
Earnings Date	2026-08-04
Earnings Time	bmo
EBIT	$-1.8B
EBITDA	$-1.2B
EPS	$-5.89
F Score	3
FCF	$725.8M
FCF EV Yield	9.01x
FCF Per Share	$2.87
Financing CF	-14,643,145
Fiscal Year End	December
Founded	2,008
Goodwill	425,006,682
Income Tax	$90.7M
Investing CF	-1,227,602,905
Ipr	519.7
Iprfo	463.3
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-05
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-03-10
Ma150	97.41
Ma150ch	-4.58%
Ma20	92.37
Ma20ch	0.63%
Net CF	-283,062,377
Next Earnings Date	2026-08-04
Open	92.3
Optionable	Yes
P FCF Ratio	32.39
P FCF Ratio SBC	37.28
P OCF Ratio	25.12
P OCF Ratio SBC	27.97
Position In Range	41.63
Ppne	1,512,129,036.8
Pre Close	92.45
Price Date	2026-07-29
Ptbv Ratio	1.21
Relative Volume	0.98x
Revenue	3,234,405,626x
SBC By Revenue	2.96x
Share Based Comp	95,814,597
Tax By Revenue	2.81x
Tr6m	-19.98%
Volume	739,945
Z Score	7.3

BioNTech SE (BNTX)

Coverage state: Market snapshot only — no published research

Generate the first BNTX analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · BNTX

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All BNTX indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on BNTX

Frequently asked questions